Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials During the COVID-19 Pandemic

Juliet Emamaullee1, Michael Bowdish1, Pui Yuk Yan2

  • 1Department of Surgery, University of Southern California, Los Angeles, California; Keck School of Medicine, University of Southern California, Los Angeles, California.

Insights

The COVID-19 pandemic disrupted clinical trials, necessitating rapid adaptation. This study outlines strategies for safely continuing research and launching new trials during the crisis.

Area of Science:

  • Clinical Research
  • Pandemic Response
  • Surgical Trials

Background:

  • The COVID-19 pandemic significantly disrupted ongoing clinical trials.
  • There is an urgent need for effective COVID-19 treatments, highlighting the importance of rigorous research.
  • Public health measures like "stay at home" orders impacted research personnel and study conduct.

Purpose of the Study:

  • To describe the adaptive strategies of a clinical trials unit during the COVID-19 pandemic.
  • To ensure participant safety and data integrity in ongoing and new clinical studies.
  • To demonstrate the successful transition to remote operations without compromising research quality.

Main Methods:

  • Implementing safety protocols for study participants.
  • Adapting study procedures for remote data collection and participant monitoring.
  • Leveraging existing infrastructure for rapid trial initiation and management.
  • Establishing a remote work environment for research staff.

Main Results:

  • Successful continuation of ongoing clinical studies with necessary adjustments.
  • Safe enrollment and follow-up of participants in studies offering potential benefits.
  • Rapid implementation of new clinical trials focused on COVID-19.
  • Effective transition to a remote workforce, maintaining research operations.

Conclusions:

  • A dedicated Division of Clinical Research within a surgical department can effectively manage crisis situations.
  • Adaptability and strategic planning are crucial for maintaining clinical research during pandemics.
  • The established infrastructure facilitated a safe and efficient pivot to remote research operations.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
312